Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Botulinum Toxin for Treatment of Gastroparesis

Focus of the Report: Use of botulinum toxin (BTX) for treatment of gastroparesis.

Technology Description: BTX, a neurotoxin produced by the bacterium Clostridium botulinum, inhibits the release of the neurotransmitter acetylcholine at the neuromuscular junction and causes muscle paralysis. B…

Concentrated Bone Marrow Aspirate for Spinal Surgery

Focus of the Report: This report evaluates the use of autologous concentrated bone marrow aspirate (CBMA) for spinal fusion surgeries.

Technology Description: Autologous CBMA may be implanted during spinal fusion procedures alone or as an adjunct to other bone grafting materials. CBMA …

Expandable Interbody Cages for Lumbar Spinal Fusion

Focus of the Report: This report focuses on expandable interbody cages (EIC) for lumbar fusion in patients with degenerative disc disease (DDD).

Technology Description: Interbody fusion procedures involve the removal of a pathologic disc and insertion of interbody cages and bone grafts…

Micro-Ultrasound for Diagnosis of Prostate Cancer

Focus of the Report: In its application to prostate biopsy, micro-ultrasound (mUS), also known as high-resolution ultrasound (US), not only provides guidance for the biopsy needle but also allows identification of features that cannot be revealed by conventional US. Thus, mUS has the potential to identify cancerous lesions that might otherwis…

Micro-Ultrasound for Diagnosis of Prostate Cancer

Focus of the Report: In its application to prostate biopsy, micro-ultrasound (mUS), also known as high-resolution ultrasound (US), not only provides guidance for the biopsy needle but also allows identification of features that cannot be revealed by conventional US. Thus, mUS has the potential to identify cancerous lesions that might otherwis…

Botulinum Toxin for Treatment of Raynaud Phenomenon

Focus of the Report: For use of botulinum toxin (BTX) for Raynaud phenomenon (RP).

Technology Description: BTX has been investigated as a treatment for various chronic painful conditions because of its potential to reduce muscle tension and modulate pain receptor activity in the central nervous system. For the treatment of RP, there is currently no sta…